Pronounce: TOR-ip-A-li-mab
Classification: Monoclonal Antibody
The immune system works by creating antibodies, which are proteins that attach to antigens found on the surface of a cell. The antibody “calls” the immune system to attack the cell it is attached to, resulting in the immune system killing the cell. Monoclonal antibodies are created in a lab to attach to the antigens found on specific types of cancer cells. These antibodies can work in different ways, including stimulating the immune system to kill the cell, blocking cell growth, or other functions necessary for cell growth.
Toripalimab-tpzi is a type of monoclonal antibody which works to stimulate the immune system to destroy cancer cells. T-cells are a type of white blood cell that are very important to the normal functioning of the immune system. Toripalimab-tpzi works as a form of immunotherapy by binding to the "programmed death receptor" (PD1) found on T-cells to stimulate the immune system to find and kill cancer cells.
Toripalimab-tpzi is administered intravenously (IV, into a vein). The dosage and how often you receive it depends on if it is given alone or in combination with chemotherapy. Your provider will determine how many doses you should receive and how often.
Tell your care team about all your medical conditions, including those that are autoimmune in nature (Crohn’s disease, lupus, rheumatoid arthritis, etc.) as these can get worse with immunotherapy.
There are a number of things you can do to manage the side effects of toripalimab-tpzi. Talk to your care team about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
This medication stimulates your immune system. Your immune system can attack normal organs and tissues in your body, leading to serious or life-threatening complications. It is important to notify your healthcare provider right away if you develop any of the following symptoms:
Patients may experience joint or muscle pain. Arthralgia pain is like arthritis pain. You can have morning stiffness and you may feel it in a few joints at different times. It often affects the elbows, shoulders, wrists, knees, feet, pelvic and hip bones, or back. Myalgia is pain or aching within the muscle. Your oncology team can recommend medication and other strategies to relieve pain.
Fatigue is very common during cancer treatment and is an overwhelming feeling of exhaustion that is not usually relieved by rest. While on cancer treatment, and for a period after, you may need to adjust your schedule to manage fatigue. Plan times to rest during the day and conserve energy for more important activities. Exercise can help combat fatigue; a simple daily walk with a friend can help. Talk to your healthcare team for helpful tips on dealing with this side effect.
In some cases, patients can have an allergic reaction to this medication. Signs of a reaction can include shortness of breath or difficulty breathing, shivering, chest pain, rash, flushing or itching, or a decrease in blood pressure. If you notice any changes in how you feel during the infusion, let your nurse know immediately. The infusion will be slowed or stopped if this occurs.
Exposure of an unborn child to this medication could cause harm to the fetus, so you should not become pregnant or father a child while on this medication or for 4 months following the last dose. Effective birth control is necessary during treatment, even if your menstrual cycle stops or you believe you are not making sperm, you could still be fertile and conceive. You may be given a pregnancy test prior to starting treatment to confirm that you are not pregnant. A woman should not breastfeed while receiving this medication and for 4 months after treatment.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania